¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"subarachnoid ureteral shunt"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • arteriovenous shunt
    µ¿Á¤¸Æ¼ÇÆ®
  • bypass shunt
    ¿ìȸ¼ÇÆ®
  • cardiovascular shunt
    ½ÉÀåÇ÷°ü¼ÇÆ®
  • intracardiac shunt
    ½ÉÀå³»¼ÇÆ®
  • left-to-right shunt
    Á¿ì¼ÇÆ®
  • lumboperitoneal shunt
    ¿äÃߺ¹°­¼ÇÆ®
  • mesocaval shunt
    ´ëÁ¤¸Æ°£¸·¼ÇÆ®
  • mesocaval shunt operation
    ´ëÁ¤¸Æ°£¸·¼ÇÆ®¼ö¼ú
  • portacaval shunt
    ¹®¸Æ´ëÁ¤¸Æ¼ÇÆ®
  • portocaval shunt operation
    ¹®¸Æ´ëÁ¤¸Æ¼ÇÆ®¼ö¼ú
  • portosystemic shunt
    ¹®¸ÆÀü½Å¼ÇÆ®
  • peritoneovenous shunt
    º¹°­Á¤¸Æ¼ÇÆ®
  • right to left shunt
    ¿À¸¥¿ÞÂÊ¼ÇÆ®, ¿ìÁÂ¼ÇÆ®
  • splenorenal shunt
    Áö¶óÄáÆÏÁ¤¸Æ¼ÇÆ®, ºñÁ¤¸Æ½ÅÁ¤¸Æ¼ÇÆ®
  • subduro-peritoneal shunt
    ³ú°æ¸·ÇϺ¹°­¼ÇÆ®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ureteral stump
    ¿ä°üÀ߸°³¡, ¿ä°ü¹Øµ¿
  • ureteral
    ¿ä°ü-
  • arteriovenous shunt
    µ¿Á¤¸ÆÁö¸§±æ, µ¿Á¤¸ÆÁö¸§¼ú
  • bypass shunt
    ¿ìȸ·ÎÁö¸§±æ, ¿ìȸ·ÎÁö¸§¼ú
  • cardiaovascular shunt
    ½ÉÀåÇ÷°üÁö¸§±æ
  • shunt circuit
    Áö¸§±æ
  • shunt effect
    Áö¸§±æÈ¿°ú, ¼ÇƮȿ°ú
  • intracardiac shunt
    ½ÉÀå³»Áö¸§±æ
  • mesocaval shunt operation
    âÀÚ°£¸·´ëÁ¤¸Æ¿¬°á¼ú, Àå°£¸·Á¤¸Æ´ëÁ¤¸Æ¿¬°á¼ú
  • shunt malfunction
    Áö¸§±æ±â´ÉÀå¾Ö
  • shunt operation
    Áö¸§¼ú, ´Ü¶ô¼ö¼ú
  • paracellular shunt
    ¼¼Æ÷ÁÖÀ§Áö¸§±æ
  • portacaval shunt
    ¹®¸Æ´ëÁ¤¸ÆÁö¸§(¼ú), ¹®¸Æ´ëÁ¤¸Æ¿¬°á(¼ú)
  • portosystemic shunt
    ¹®¸ÆÀü½Å¼øÈ¯Áö¸§¼ú, ¹®¸ÆÀü½Å¼øÈ¯¿¬°á¼ú
  • renal shunt
    ÄáÆÏÇ÷·ùÁö¸§±æ, ½ÅÀåÇ÷·ùÁö¸§±æ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • subarachnoid cisterns
    °Å¹Ì¸·ÇÏÁ¶(¡­ù»ðË).
  • subarachnoid cisterns
    °Å¹Ì¸·¹Ø¼öÁ¶
  • subarachnoid fluid
    °Å¹Ì¸·Çϼö¾×(¡­âÐäû).
  • subarachnoid hemorrhage
    °Å¹Ì¸·ÇÏÃâÇ÷
  • subarachnoid hemorrhage
    °Å¹Ì¸·ÇÏÃâÇ÷(¡­õóúì). ÁöÁÖ¸·ÇÏÃâÇ÷(ò»ñÈØ¯ù»õóúì)
  • subarachnoid neurolytic block
    °Å¹Ì¸·ÇϽŰæÆÄ±«Á¦Â÷´Ü.
  • subarachnoid peritoneostomy
    ÁöÁÖ¸·ÇϺ¹°­¹®ÇÕ(¼ú)(ÁöÁÖ¸·ÇϺ¹°­¹®ÇÕ¼ú).
  • subarachnoid space
    °Å¹Ì¸·¹Ø°ø°£, °Å¹Ì¸·Çϰø°£(¡­ÍöÊà).
  • subarachnoid space
    °Å¹Ì¸·¹Ø°ø°£
  • subarachnoid space
    °Å¹Ì¸·Çϰø°£, ÁöÁÖ¸·Çϰø°£(ÍöÊà)
  • arteriovenous shunt
    µ¿Á¤¸Æ¼ÇÆ®, µ¿Á¤¸Æ´Ü¶ô(¡­Ó­Õ©)
  • arteriovenous shunt
    µ¿Á¤¸Æ¼ÇÆ®, µ¿Á¤¸Æ´Ü¶ô(¡­´Ü¶ô).
  • bypass shunt
    ¿ìȸ·Î ´Ü¶ô(éæüÞÖØÓ­Õ©).
  • bypass shunt
    ȸ·Î°£µµ, ȸ·Î´Ü¶ô(ȸ·Î´Ü¶ô), ¿ìȸ·Î´Ü¶ô.
  • bypass shunt
    ¼øÈ­ [½Å¿Ü,ÈäºÎ]ȸ ·Î°£µµ, ȸ·Î´Ü¶ô(üßÖØÓ­Õ©), ¿ìȸ·Î´Ü¶ô.
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ureteral colic
    ¿ä°ü»êÅë
  • ureteral dilatation
    ¿ä°üÈ®Àå(Áõ)
  • ureteral orifice
    ¿ä°ü±¸
  • ureteral stone
    ¿ä°ü°á¼®
  • ureteral stricture
    ¿ä°üÇùÂø
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
VP shunt Ventriculo-Peritoneal shunt
SP sacroposterior; sacrum to pubis; salivary progesterone; schizotypal personality; semi-private [room]...
CSAVP cerebral subarachnoid venous pressure
SA salicylic acid; saline [solution]; salt added; sarcoidosis; sarcoma; scalenus anticus; secondary ame...
SAB Scientific Advisory Board; serum albumin; significant asymptomatic bacteriuria; sinoatrial block; So...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DSRS Distal splenorenal shunt
HMPS Hexose monophosphate shunt
HMS Hexose-monophosphate shunt
PVS Peritoneo Venous Shunt
PCS Portacaval shunt
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
ureteral pseudo-diverticulosis <radiology> Proliferation of von Brunn's nests, often missed on IVP may lead to need retrograde urogram, pre-malignant may lead to TCC
(12 Dec 1998)
arteriovenous shunt <anatomy, surgery> A direct connection between an artery and vein. Most often due to the surgical joining of an artery and a vein under the skin for the purpose of haemodialysis.
Larger arteriovenous shunts can create significant extra workload on the heart since arterial blood is diverted back to the venous circulation before it has a chance to deliver nutrients and oxygen to the body tissues.
(20 Jun 2000)
A-V shunt <anatomy, surgery> A direct connection between an artery and vein. Most often due to the surgical joining of an artery and a vein under the skin for the purpose of haemodialysis.
Larger arteriovenous shunts can create significant extra workload on the heart since arterial blood is diverted back to the venous circulation before it has a chance to deliver nutrients and oxygen to the body tissues.
(20 Jun 2000)
Blalock shunt Subclavian artery to pulmonary artery shunt to increase pulmonary circulation in cyanotic heart disease with decreased pulmonary flow.
(05 Mar 2000)
Blalock-Taussig shunt A palliative subclavian artery to pulmonary artery anastomosis.
(05 Mar 2000)
Rapoport-Luebering shunt Part of the glycolytic pathway characteristic of human erythrocytes in which 2,3-bisphosphoglycerate (2,3-P2Gri) is formed as an intermediate between 1,3-P2Gri and 3-phosphoglycerate; 2,3-P2Gri is an important regulator of the affinity of haemoglobin for oxygen.
(05 Mar 2000)
ventriculoperitoneal shunt <procedure> A surgical procedure to insert a communicating catheter to relieve intracranial pressure caused by hydrocephalus.
In this procedure the cerebrospinal fluid is shunted from the ventricles of the brain into the peritoneal cavity via a surgically implanted tube.
(27 Sep 1997)
Glenn shunt A means of palliating cyanotic heart disease by anastomosing the right pulmonary artery to the superior vena cava.
Synonym: cavopulmonary shunt, Glenn shunt.
(05 Mar 2000)
cavopulmonary shunt A means of palliating cyanotic heart disease by anastomosing the right pulmonary artery to the superior vena cava.
Synonym: cavopulmonary shunt, Glenn shunt.
(05 Mar 2000)
renal-splenic venous shunt Anastomosis of the splenic vein to the left renal vein, usually end-to-side, for control of portal hypertension.
Synonym: renal-splenic venous shunt.
(05 Mar 2000)
vp shunt <procedure> A surgical procedure to insert a communicating catheter to relieve intracranial pressure caused by hydrocephalus.
In this procedure the cerebrospinal fluid is shunted from the ventricles of the brain into the peritoneal cavity via a surgically implanted tube.
(27 Sep 1997)
pentose monophosphate shunt <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate.
Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses.
In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection.
Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose.
(18 Nov 1997)
reversed shunt Right-to-left shunt that had previously been a left-to-right shunt; rarely the opposite.
(05 Mar 2000)
mesocaval shunt Anastomosis of the side of the superior mesenteric vein to the proximal end of the divided inferior vena cava, for control of portal hypertension, h-shunt anastomosis of the inferior vena cava to the superior mesenteric vein, using a synthetic conduit or autologous vein.
(05 Mar 2000)
peritoneovenous shunt An operation for the continuous emptying of ascitic fluid into the venous system. Fluid removal is based on intraperitoneal and intrathoracic superior vena cava pressure differentials and is performed via a pressure-sensitive one-way valve connected to a tube traversing the subcutaneous tissue of the chest wall to the neck where it enters the internal jugular vein and terminates in the superior vena cava. It is used in the treatment of intractable ascites.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á